Abstract
Dry Eye Disease (DED) is defined as a multifactorial condition that results in discomfort, visual disturbance, tear film instability and damage to the ocular surface. It is characterized by the increased osmolarity of the tear film and inflammation of the ocular surface. Tear film stability is maintained by the coordinated functions of the outer lipid monolayer with its critical composition and the contents of aqueous interface. This chapter discusses the structure and function attributing to tear film integrity, mucoadhesive polymers used in tear substitutes/lubricants, tear secretagogues agents, anti-inflammatory immunosuppressants, and use of autologous serum, umbilical cord serum for the management of dry eye.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal HC, Anuradha VK, Titiyal JS, Gupta V. Effect of intraoperative intracameral 2% hydroxypropyl methylcellulose viscoelastic during trabeculectomy. Ophthalmic Surg Lasers Imaging. 2005;36(4):280–5.
Akpek EK, Lindsley KB, Adyanthaya RS, Swamy R, Baer AN, McDonnell PJ. Treatment of Sjögren’s syndrome-associated dry eye an evidence-based review. Ophthalmology. 2011;118(7):1242–52.
Anitua E, Muruzabal F, Tayebba A, Riestra A, Perez VL, Merayo-Lloves J, Orive G. Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Acta Ophthalmol. 2015. doi:10.1111/aos.12710 [Epub ahead of print].
Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sci. 1998;43(9 Suppl):5S–13.
Arita R, Suehiro J, Haraguchi T, Maeda S, Maeda K, Tokoro H, Amano S. Topical diquafosol for patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2013;97(6):725–9. doi:10.1136/bjophthalmol-2012-302668.
Bansil R, Turner BS. Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci. 2006;11:164–70.
Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res. 2004;78(3):347–60.
Bucolo C, Melilli B, Piazza C, Zurria M, Drago F. Ocular pharmacokinetics profile of different indomethacin topical formulations. J Ocul Pharmacol Ther. 2011;27(6):571–6.
Fox RI, Stern M, Michelson P. Update in Sjögren syndrome. Curr Opin Rheumatol. 2000;12(5):391–8.
Gipson IK, Argüeso P. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol. 2003;231:1–49.
Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol. 1977;22(2):69–87.
Hütz WW, Eckhardt HB, Kohnen T. Comparison of viscoelastic substances used in phacoemulsification. J Cataract Refract Surg. 1996;22(7):955–9.
IDEW-2007. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75–92.
Itakura H, Kashima T, Itakura M, Akiyama H, Kishi S. Topical rebamipide improves lid wiper epitheliopathy. Clin Ophthalmol. 2013;7:2137–41. doi:10.2147/OPTH.S5451. Epub 2013 Oct 31.
Johnson ME, Murphy PJ. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res. 2004;23:449–74.
Kashima T, Itakura H, Akiyama H, Kishi S. Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal. Clin Ophthalmol. 2014;8:1003–10. doi:10.2147/OPTH.S40798. eCollection 2014.
Keating GM. Diquafosol Ophthalmic Solution 3%: A Review of Its Use in Dry Eye. Drugs. 2015;75(8):911–22.
Koh S, Maeda N, Ikeda C, Takai Y, Fujimoto H, Oie Y, Soma T, Tsujikawa M, Nishida K. Effect of instillation of eyedrops for dry eye on optical quality. Invest Ophthalmol Vis Sci. 2013;54(7):4927–33. doi:10.1167/iovs.13-12409.
Kohashi M, Ishimaru N, Arakaki R, Hayashi Y. Effective treatment with oral administration of rebamipide in a mouse model of Sjögren’s syndrome. Arthritis Rheum. 2008;58(2):389–400. doi:10.1002/art.23163.
Lau OC, Samarawickrama C, Skalicky SE. P2Y2 receptor agonists for the treatment of dry eye disease: a review. Clin Ophthalmol. 2014;8:327–34.
McCulley JP, Shine WE. The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res. 2004;78(3):361–5.
McDermott AM, et al. Pathways of corneal and ocular surface inflammation: a perspective from the Cullen Symposium. Ocul Surf. 2005;3(4):S131–8.
Moscovici BK, Holzchuh R, Sakassegawa-Naves FE, Hoshino-Ruiz DR, Albers MB, Santo RM, Hida RY. Treatment of Sjögren’s syndrome dry eye using 0.03% tacrolimus eye drop: prospective double-blind randomized study. Cont Lens Anterior Eye. 2015;38(5):373–8. doi:10.1016/j.clae.2015.04.004. Epub 2015 May 5.
Moshirfar M, Pierson K, Hanamaikai K, Santiago-Caban L, Muthappan V, Passi SF. Artificial tears potpourri: a literature review. Clin Ophthalmol. 2014;8:1419–33.
Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, Tsubota K. Therapeutic effect of cevimeline on dry eye in patients with Sjögren’s syndrome: a randomized, double-blind clinical study. Am J Ophthalmol. 2004;138(1):6–17.
Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren’s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum. 2002;46(3):748–54.
Piwkumsribonruang N, Somboonporn W, Luanratanakorn P, Kaewrudee S, Tharnprisan P, Soontrapa S. Effectiveness of hormone therapy for treating dry eye syndrome in postmenopausal women: a randomized trial. J Med Assoc Thai. 2010;93(6):647–52.
Pfau B, Kruse FE, Rohrschneider K, Zorn M, Fiehn W, Burk RO, Völcker HE. Comparison between local and systemic administration of cyclosporin A on the effective level in conjunctiva, aqueous humor and serum. Ophthalmologe. 1995;92(6):833–9.
Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304(4):452–60. doi:10.1001/jama.2010.1014.
RÃos JD, Shatos M, Urashima H, Tran H, Dartt DA. OPC-12759 increases proliferation of cultured rat conjunctival goblet cells. Cornea. 2006;25(5):573–81.
RÃos JD, Shatos MA, Urashima H, Dartt DA. Effect of OPC-12759 on EGF receptor activation, p44/p42 MAPK activity, and secretion in conjunctival goblet cells. Exp Eye Res. 2008;86(4):629–36.
Saettone MF, Monti D, Torracca MT, Chetoni P. Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations. J Ocul Pharmacol. 1994;10(1):83–92.
Scott G, Yiu SC, Wasilewski D, Song J, Smith RE. Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women. Am J Ophthalmol. 2005;139(6):1109–10.
Scuderi G, Contestabile MT, Gagliano C, Iacovello D, Scuderi L, Avitabile T. Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: a randomized clinical trial. Can J Ophthalmol. 2012;47(6):489–92.
Simmons PA, Donshik PC, Kelly WF, Vehige JG. Conditioning of hydrogel lenses by a multipurpose solution containing an ocular lubricant. CLAO J. 2001;27(4):192–4.
Snibson GR, Greaves JL, Soper ND, Tiffany JM, Wilson CG, Bron A. Ocular surface residence times of artificial tear solutions. Cornea. 1992;11(4):288–93.
Takeji Y, Urashima H, Aoki A, Shinohara H. Rebamipide increases the mucin-like glycoprotein production in corneal epithelial cells. J Ocul Pharmacol Ther. 2012;28(3):259–63.
Tandon R, Shiva P. Gantyala A, Velpandian T, et al. Study of ocular bioavailability of oral rebamipide to determine its potential value in the management of dry eye. Proceedings of ARVO. 2012.
Terakado K, Yogo T, Kohara Y, Soeta S, Nezu Y, Harada Y, Hara Y, Amasaki H, Tagawa M. Conjunctival expression of the P2Y2 receptor and the effects of 3% diquafosol ophthalmic solution in dogs. Vet J. 2014;202(1):48–52. doi:10.1016/j.tvjl.2014.05.022. Epub 2014 May 22.
Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit. 1995;17(6):584–91.
Tiffany JM. The normal tear film. Dev Ophthalmol. 2008;41:1–20. doi:10.1159/000131066.
Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury 3rd PL, Tran-Johnson TK, Muscoplat CC, Trivedi M, Goldlust B, Gallagher SC. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med. 1999;159(2):174–81.
Wagh VD, Inamdar B, Samanta MK. Polymers used in ocular dosage form and drug delivery systems. Asian J Pharm. 2008;2:12–7.
Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. 2007;144(1):86–92. Epub 2007 May 9.
Zhao H, Jumblatt JE, Wood TO, Jumblatt MM. Quantification of MUC5AC protein in human tears. Cornea. 2001;20(8):873–7.
Zhou XQ, Wei RL. Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis. Cornea. 2014;33(7):760–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Velpandian, T., Moksha, L. (2016). Mucoadhesive Polymers and Ocular Lubricants. In: Velpandian, T. (eds) Pharmacology of Ocular Therapeutics. Adis, Cham. https://doi.org/10.1007/978-3-319-25498-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-25498-2_10
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-25496-8
Online ISBN: 978-3-319-25498-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)